The Central Designer technology provides one central and independent environment for building studies, where all teams work within a centralized system and one that allows for reuse of study components, said Phase Forward.
These Phase I trials were highly complex, involving more than 1,500 forms in aggregate, and the teamwork between the two organizations significantly improved the efficiency of the study builds, added Phase Forward.
Luc Braeken, vice president of global clinical management at SGS, said: “Our first priority is ensuring that our customers have access to the best, most innovative technology for clinical trials. Our many years of experience with Phase Forward’s InForm technology, and our success with Central Designer, coupled with Phase Forward’s premier services team, has helped further position us in the Phase I space.”